MAM
Livguard appoints Sameer Nagpal as MD & CEO to power up its next phase of clean energy growth
MUMBAI: Livguard just hit the power button on a bold new chapter. The energy storage and solar solutions brand under the SAR Group announced the appointment of Sameer Nagpal as its new MD & CEO on 23 April 2025.
Nagpal, a seasoned business leader with more than 30 years of cross-industry experience, is expected to supercharge Livguard’s growth in the renewable energy sector—a space that’s heating up with India’s push for sustainability and self-reliance.
Before plugging into Livguard, Nagpal led transformation and growth across firms like Dalmia Bharat, Shalimar Paints, Trane Technologies, Zicom Electronic Security Systems and Carrier Corporation. His CV reads like a blueprint for business turnarounds, and his knack for profit-first strategies and team-led growth makes him well-suited to scale a brand navigating India’s evolving energy landscape.
“I am excited to join this dynamic and forward-thinking company at a time when the energy industry is undergoing a fundamental shift… My vision for the future of energy solutions is rooted in Livguard’s core values of innovation, reliability, and customer-centricity,” said Nagpal.
SAR Group founder Rakesh Malhotra added, “Sameer’s exceptional leadership and proven ability to drive transformative growth align perfectly with our vision… His experience and strategic mindset make him an ideal fit to lead Livguard into its next phase of growth.”
With India’s energy ambitions accelerating, particularly in solar power and lithium-ion storage, Livguard is positioning itself as a front-runner. Under Nagpal’s watch, the company aims to scale across residential, commercial and industrial segments, delivering smart energy solutions without burning out customer wallets.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
